Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability - Concepedia

Concepedia

Publication | Open Access

Functional Characterization of Abicipar-Pegol, an Anti-VEGF DARPin Therapeutic That Potently Inhibits Angiogenesis and Vascular Permeability

DOI Full Paper Access

72

Citations

55

References

2018

Year

Gerard A. Rodrigues, Matthew D. Mason, Lori‐Ann Christie, Candice Hansen, Lisa M. Hernández, James A. Burke, Keith A. Luhrs, Thomas C. Hohman

Investigative Ophthalmology & Visual Science

Abstract

These data support the testing of abicipar as a treatment for retinal diseases characterized by neovascularization and vascular leak.

References

	Year	Citations

Page 1